Acadia
  • Home
  • Contact
  • Home
  • About
    • Management Team
    • Board Of Directors
    • Our Purpose, Mission & Values
    • History
  • Product
  • Pipeline
    • Dementia-Related Psychosis
    • Rett Syndrome
    • Schizophrenia – Negative Symptoms
    • Early Stage Clinical Programs
  • Resources
    • Parkinson’s Disease Psychosis
    • Clinical Trials
    • Investigator Initiated Trials
    • Medical Education Grants
    • Scientific Publications
  • Partnering
  • Investors
    • Stock Information
    • News Releases
    • Events & Presentations
    • Sec Filings
    • Corporate Governance
    • Financial Information
    • Analyst Coverage
    • Annual Report and Proxy
    • Information Request
    • Email Alerts
  • Media
  • Careers
  • Contact
  • About
    • Management Team
    • Board Of Directors
    • Our Purpose, Mission & Values
    • History
  • Product
  • Pipeline
    • Dementia-Related Psychosis
    • Rett Syndrome
    • Schizophrenia – Negative Symptoms
    • Early Stage Clinical Programs
  • Resources
    • Parkinson’s Disease Psychosis
    • Clinical Trials
    • Investigator Initiated Trials
    • Medical Education Grants
    • Scientific Publications
  • Partnering
  • Investors
    • Stock Information
    • News Releases
    • Events & Presentations
    • Sec Filings
    • Corporate Governance
    • Financial Information
    • Analyst Coverage
    • Annual Report and Proxy
    • Information Request
    • Email Alerts
  • Media
  • Careers
  • Pipeline
  • Dementia-Related Psychosis
  • Rett Syndrome
  • Schizophrenia – Negative Symptoms
  • Early Stage Clinical Programs

Our Pipeline

Our pipeline includes innovative product candidates in CNS areas:

Pipeline Chart 01-11-21Pipeline Chart 01-11-21

The safety and efficacy of investigational agents or an investigational use of an approved product (referenced above) have not been established or approved by the FDA

  • Print page
  • Share
  • Privacy
  • Cookies
  • Privacy
    Shield
  • Terms
  • Email

© 2021 Acadia Pharmaceuticals Inc. Acadia and NUPLAZID are registered trademarks of Acadia Pharmaceuticals Inc. All rights reserved.

This website uses cookies to improve and customize your experience on our website. By using this website without changing your cookie settings in your browser, you agree to our use of cookies. For further details on cookies, how we use cookies and how to delete or block the use of cookies, please read our Cookie Policy.

ACCEPT